Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Ethyl Gallate: Promising Cytoprotective against HIV-1-Induced Cytopathy and Antiretroviral-Induced Cytotoxicity

C. Muddu Krishna, JN. Kolla, HB. Bollikolla, T. Sravan Kumar Reddy, S. Asha

. 2023 ; 2023 (-) : 6727762. [pub] 20230712

Status not-indexed Language English Country United States

Document type Journal Article

INTRODUCTION: HIV-1 infection in cell culture is typically characterized by certain cytopathic effects such as vacuolization of cells and development of syncytia, which further lead to cell death. In addition, the majority of drugs during HIV treatment exhibit serious adverse effects in patients, apart from their beneficial role. During the screening of cytoprotective agents to protect the cells from HIV-1-associated cell death and also drug-associated toxicity, antioxidants from a natural source are assumed to be a choice. A well-known antioxidant, ethyl gallate (EG), was selected for cytoprotection studies which have already been proven as an anti-HIV agent. OBJECTIVE: The main objective of the study was to explore the cytoprotective potential of EG against HIV-1-induced cytopathic effect and antiretroviral drug toxicity. METHODS: DPPH free radical scavenging assay was performed with EG to find the effective concentration for antioxidant activity. HIV-1infection-associated cytopathic effects and further rescue by EG were studied in MT-2 lymphocytes by the microscopic method and XTT cytopathic assays. The cellular toxicity of different antiretroviral drugs in different cell lines and the consequent cytoprotective effectiveness of EG were investigated using an MTT cell viability assay. RESULTS: Like ascorbic acid, EG exhibited promising antioxidant activity. HIV-1 infection of MT2 cells induces cell death often referred to as the cytopathic effect. In addition, the usage of antiretroviral drugs also causes severe adverse effects like cytotoxicity. In this context, EG was tested for its cytoprotective properties against HIV-1-induced cytopathic effect and drug-mediated cellular toxicity. EG reclaimed back the MT2 cells from HIV-1-induced cell death. Antiretroviral drugs, such as ritonavir, efavirinz, AZT, and nevirapine, were tested for their toxicity and induced more cell death at higher concentrations in different tissue models such as the liver (THLE-3), lung (AEpiCM), colorectal (HT-29), and brain (U87 MG). Pretreated cells with EG were rescued from the toxic doses of ART. CONCLUSION: EG was found to be exhibited cytoprotection not only from HIV-1-linked cell death but also from the chemotoxicity of antiretroviral drugs. Evidently, EG could be a cytoprotective supplement in the management of AIDS along with its enormous antioxidant benefits.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23015742
003      
CZ-PrNML
005      
20231020093442.0
007      
ta
008      
231010s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1155/2023/6727762 $2 doi
035    __
$a (PubMed)37475729
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Muddu Krishna, C $u Department of Biotechnology, VFSTR (Deemed to be University), Vadlamudi, Guntur, AP, India $u Discovery Biology, Hetero Research Foundation, Hyderabad, Telangana, India
245    10
$a Ethyl Gallate: Promising Cytoprotective against HIV-1-Induced Cytopathy and Antiretroviral-Induced Cytotoxicity / $c C. Muddu Krishna, JN. Kolla, HB. Bollikolla, T. Sravan Kumar Reddy, S. Asha
520    9_
$a INTRODUCTION: HIV-1 infection in cell culture is typically characterized by certain cytopathic effects such as vacuolization of cells and development of syncytia, which further lead to cell death. In addition, the majority of drugs during HIV treatment exhibit serious adverse effects in patients, apart from their beneficial role. During the screening of cytoprotective agents to protect the cells from HIV-1-associated cell death and also drug-associated toxicity, antioxidants from a natural source are assumed to be a choice. A well-known antioxidant, ethyl gallate (EG), was selected for cytoprotection studies which have already been proven as an anti-HIV agent. OBJECTIVE: The main objective of the study was to explore the cytoprotective potential of EG against HIV-1-induced cytopathic effect and antiretroviral drug toxicity. METHODS: DPPH free radical scavenging assay was performed with EG to find the effective concentration for antioxidant activity. HIV-1infection-associated cytopathic effects and further rescue by EG were studied in MT-2 lymphocytes by the microscopic method and XTT cytopathic assays. The cellular toxicity of different antiretroviral drugs in different cell lines and the consequent cytoprotective effectiveness of EG were investigated using an MTT cell viability assay. RESULTS: Like ascorbic acid, EG exhibited promising antioxidant activity. HIV-1 infection of MT2 cells induces cell death often referred to as the cytopathic effect. In addition, the usage of antiretroviral drugs also causes severe adverse effects like cytotoxicity. In this context, EG was tested for its cytoprotective properties against HIV-1-induced cytopathic effect and drug-mediated cellular toxicity. EG reclaimed back the MT2 cells from HIV-1-induced cell death. Antiretroviral drugs, such as ritonavir, efavirinz, AZT, and nevirapine, were tested for their toxicity and induced more cell death at higher concentrations in different tissue models such as the liver (THLE-3), lung (AEpiCM), colorectal (HT-29), and brain (U87 MG). Pretreated cells with EG were rescued from the toxic doses of ART. CONCLUSION: EG was found to be exhibited cytoprotection not only from HIV-1-linked cell death but also from the chemotoxicity of antiretroviral drugs. Evidently, EG could be a cytoprotective supplement in the management of AIDS along with its enormous antioxidant benefits.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kolla, J N $u CZ-OPENSCREEN, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $1 https://orcid.org/0000000232422262
700    1_
$a Bollikolla, Hari Babu $u Department of Chemistry, Acharya Nagarjuna University, NNagar, Guntur-522510, AP, India
700    1_
$a Sravan Kumar Reddy, T $u Discovery Biology, Hetero Research Foundation, Hyderabad, Telangana, India
700    1_
$a Asha, S $u Department of Biotechnology, VFSTR (Deemed to be University), Vadlamudi, Guntur, AP, India $1 https://orcid.org/0000000217887272
773    0_
$w MED00168940 $t Advances in virology $x 1687-8639 $g Roč. 2023, č. - (2023), s. 6727762
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37475729 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231010 $b ABA008
991    __
$a 20231020093435 $b ABA008
999    __
$a ok $b bmc $g 1997243 $s 1202104
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 2023 $c - $d 6727762 $e 20230712 $i 1687-8639 $m Advances in Virology $n Adv Virol $x MED00168940
LZP    __
$a Pubmed-20231010

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...